Quilaban Pharma Trading Private Limited, a active private limited company, was established on 30 May 2013 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the support service to organizations sector, it holds CIN: U51502MH2013PTC243798. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.10 Cr and a paid-up capital of ₹1.04 Cr.
It upholds a compliant status. Its leadership includes Naazma Sagheer Ahmad Khan (Director), Sergio Manuel Joao Dos Moreira Luciano (Director). Past directors included Naazma Sagheer Ahmad Khan, Karen Maria Irma Jean Joseph Van Uffel Ferreira, Jorge Paulo Jose Rodrigues Lima Mateus Silveira. Its latest AGM occurred on 18 August 2025, with the balance sheet filed on 31 March 2025. It is based at 503 Sai Samarth, 5Th Floor, Deonar Village Road, Deonar, Mumbai, Maharashtra, 400088.
U51502MH2013PTC243798
243798
30 May 2013
₹1.10 Cr
₹1.04 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Quilaban Pharma Trading Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naazma Sagheer Ahmad Khan | Director | 28 May 2019 | Current |
| Sergio Manuel Joao Dos Moreira Luciano | Director | 27 May 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 May 2019 | Past |
| Pramod Abcsdd | Director | 25 Sep 2023 | Past |
| Pramod Abcsdd | Director | 15 Nov 2022 | Past |
| Pramod Abcsdd | Director | 15 Jun 2019 | Past |
| Pramod Abcsdd | Director | 20 Jun 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Quilaban Pharma Trading Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 70.62% increase. The company also saw a substantial improvement in profitability, with a 16.52% increase in profit. The company's net worth moved up by a moderate rise of 7.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Quilaban Pharma Trading had a promoter holding of 99.04% and a public holding of 0.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Quilaban Pharma Trading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Quilaban Pharma Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quilaban Pharma Trading's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Quilaban Pharma Trading Private Limited last Annual general meeting of members was held on 18 Aug 2025 as per latest MCA records. was documented.
Quilaban Pharma Trading Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Naazma Sagheer Ahmad Khan was appointed as a Director was appointed as a Director on 28 May 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
The activity Sergio Manuel Joao Dos Moreira Luciano was appointed as a Director was appointed as a Director on 27 May 2016 & has been associated with this company since 9 years 7 months . was completed.
Progress on Quilaban Pharma Trading Private Limited was registered on 30 May 2013 with Roc Mumbai & aged 12 years 6 months as per MCA records. was documented.
The CIN of Quilaban Pharma Trading Private Limited is U51502MH2013PTC243798.
Quilaban Pharma Trading Private Limited is headquartered at 503 Sai Samarth, 5Th Floor, Deonar Village Road, Deonar, Mumbai, Maharashtra, 400088.
Quilaban Pharma Trading Private Limited was incorporated on 30 May 2013.
The current directors of Quilaban Pharma Trading Private Limited are
The primary industry of Quilaban Pharma Trading Private Limited is Support Service To Organizations.
Quilaban Pharma Trading Private Limited is unlisted.
The authorized capital of Quilaban Pharma Trading Private Limited is ₹1.10 Cr, and the paid-up capital is ₹1.04 Cr.
The compliance status of Quilaban Pharma Trading Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX